Jia-hui Gao
Hengyang, 421001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Triggering receptor expressed on myeloid cell family in atherosclerosis: from mechanisms to intervention strategies.
Journal: Cell communication and signaling : CCS
Published: November 14, 2025
Astragalin Retards Atherosclerosis by Promoting Cholesterol Efflux and Inhibiting the Inflammatory Response via Upregulating ABCA1 and ABCG1 Expression in Macrophages.
Journal: Journal of cardiovascular pharmacology
Published: May 11, 2020
Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
Journal: European journal of pharmacology
Published: February 15, 2020
Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: September 06, 2019
CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway.
Journal: Journal of lipid research
Published: April 30, 2019
CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: April 16, 2019
Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: February 28, 2019
Visceral adipose tissue-derived serine protease inhibitor accelerates cholesterol efflux by up-regulating ABCA1 expression via the NF-κB/miR-33a pathway in THP-1 macropahge-derived foam cells.
Journal: Biochemical and biophysical research communications
Published: April 08, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026